R. Dunn

432 total citations
5 papers, 32 citations indexed

About

R. Dunn is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Reproductive Medicine. According to data from OpenAlex, R. Dunn has authored 5 papers receiving a total of 32 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Pulmonary and Respiratory Medicine, 2 papers in Oncology and 2 papers in Reproductive Medicine. Recurrent topics in R. Dunn's work include PARP inhibition in cancer therapy (2 papers), Ovarian cancer diagnosis and treatment (2 papers) and Cancer, Lipids, and Metabolism (1 paper). R. Dunn is often cited by papers focused on PARP inhibition in cancer therapy (2 papers), Ovarian cancer diagnosis and treatment (2 papers) and Cancer, Lipids, and Metabolism (1 paper). R. Dunn collaborates with scholars based in United States and United Kingdom. R. Dunn's co-authors include Anita Mansouri, Shibani Nicum, Jane Holmes, Linda Collins, Deborah Bradley, Susana Banerjee, René L. Roux, S.B. Kaye, David C. Smith and Charles J. Ryan and has published in prestigious journals such as Journal of Clinical Oncology, Neurology and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

R. Dunn

5 papers receiving 32 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
R. Dunn United States	3	23	18	10	5	5	5	32
Martin Hogg United Kingdom	2	22 1.0×	16 0.9×	5 0.5×	4 0.8×		2	36
Núria Álvarez Spain	3	30 1.3×	18 1.0×	12 1.2×	2 0.4×		4	47
Pilar Barretina-Ginesta Spain	4	17 0.7×	26 1.4×	8 0.8×	9 1.8×		4	33
Jung-Yun Lee South Korea	4	17 0.7×	10 0.6×	6 0.6×	3 0.6×		12	29
Yasemin Dincer Germany	2	10 0.4×	13 0.7×	14 1.4×	5 1.0×		2	30
J. Maxwell Douglas Canada	3	11 0.5×	4 0.2×	10 1.0×	5 1.0×		3	29
Mitul Shah United Kingdom	2	12 0.5×	8 0.4×	19 1.9×	6 1.2×		2	31
Junli Wang China	4	11 0.5×	9 0.5×	19 1.9×	3 0.6×	1 0.2×	11	49
Rumyana Ilieva United Kingdom	4	23 1.0×	13 0.7×	11 1.1×	1 0.2×		5	28
Florentia Fostira Greece	2	15 0.7×	19 1.1×	4 0.4×	1 0.2×		2	30

Countries citing papers authored by R. Dunn

Since Specialization

Citations

This map shows the geographic impact of R. Dunn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Dunn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Dunn more than expected).

Fields of papers citing papers by R. Dunn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Dunn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Dunn. The network helps show where R. Dunn may publish in the future.

Co-authorship network of co-authors of R. Dunn

This figure shows the co-authorship network connecting the top 25 collaborators of R. Dunn. A scholar is included among the top collaborators of R. Dunn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Dunn. R. Dunn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Chiang, Chia‐Chun, et al.. (2021). Real World Efficacy, Tolerability and Safety of Ubrogepant (2485). Neurology. 96(15_supplement). 1 indexed citations

2.

Mansouri, Anita, et al.. (2021). Randomised phase II trial of olaparib, chemotherapy or olaparib and cediranib in patients with platinum-resistant ovarian cancer (OCTOVA): a study protocol. BMJ Open. 11(1). e041463–e041463. 13 indexed citations

3.

Nicum, Shibani, Jane Holmes, R. Dunn, et al.. (2021). 722O Randomised phase II trial of olaparib compared to weekly paclitaxel or olaparib plus cediranib in patients with platinum-resistant ovarian cancer (OCTOVA). Annals of Oncology. 32. S725–S726. 10 indexed citations

4.

Bradley, Deborah, R. Dunn, Charles J. Ryan, et al.. (2007). EMD121974 (NSC 707544, cilengitide) in asymptomatic metastatic androgen independent prostate cancer (AIPCa) patients (pts): A randomized trial by the Prostate Cancer Clinical Trials Consortium (NCI 6372). Journal of Clinical Oncology. 25(18_suppl). 5137–5137. 7 indexed citations

5.

Ciezki, Jay P., Deborah Kuban, Howard M. Sandler, et al.. (2006). 2204. International Journal of Radiation Oncology*Biology*Physics. 66(3). S323–S324. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact